Given that PGI2 has a distinct role in treatment for PAH and exerts an antihypertrophic action in cardiomyocytes [37], [38], we decided to test gain-of-function role of HEXIM1 in the heart of PAH. The gene discussed is HEXIM1; the disease is pulmonary arterial hypertension.